 |
 |
|
 |
 |
 |
Board of Directors / Corporate Governance |
 |
 |
| ¡@
Directors and Executive Officers
Members of
our board of directors may be elected by our directors or
our shareholders. Currently, our board of directors
consists of seven directors. The following table sets
forth information regarding our directors and executive
officers.
¡@ |
|
Directors and Executive Officers |
Age |
Position/Title |
|
Dr. Biing-Seng Wu |
52 |
Chairman of the Board |
|
Jordan Wu |
49 |
President, Chief Executive Officer and Director |
|
Tien-Jen Lin |
46 |
Director |
|
Dr. Chun-Yen Chang |
72 |
Independent Director |
|
Yuan-Chuan Horng |
58 |
Independent Director |
|
Dr. Yan-Kuin Su |
61 |
Independent Director |
|
Chih-Chung Tsai |
58 |
Chief Technology Officer, Senior Vice President and Director |
|
¡@
Board Composition
Our board of directors currently consists
of five members, two of whom will be
independent directors within the meaning
of Rule 4200(a)(15) of the Nasdaq Stock
Market, Inc. Marketplace Rules, or the
Nasdaq Rules, as amended from time to
time. Other than Dr. Biing-Seng Wu and
Jordan Wu, who are brothers, there are no
family relationships between any of our
directors and executive officers. We
intend to follow home country practice
that permits our board of directors to
have less than a majority of independent
directors in lieu of complying with Rule
4350(c)(1) of the Nasdaq Rules that
require boards of U.S. companies to have a
board of directors comprised of a majority
of independent directors. Moreover, we
intend to follow home country practice
that permits our independent directors not
to hold regularly scheduled meetings at
which only independent directors are
present in lieu of complying with Rule
4350(c)(2).
¡@
¡@
¡@ |
|
 |
 |
 |